Aim: The aim of this study is to evaluate the effect of intrauterine insemination (IUI) on clinical pregnancy rates in women with polycystic ovary syndrome (PCOS) undergoing ovulation induction (OI) cycles.
Methods: We evaluated the medical records of one hundered and forty-seven infertil anovulatory women with PCOS who attended to the infertility outpatiens clinics of the current hospital. All women underwent either IUI or timed intercourse (TIC) following OI with clomiphene citrate (CC) according to their requests. Some demographic and clinical features, baseline hormone levels and treatment cycle characteristics were recorded for each woman.
Results: Of a total 147 cycles, 56 cycles were with IUI and 91 others with TIC. The IUI and TIC groups were similar in terms of age, BMI, gravidity numbers, parity numbers, number of abortion and infertility duration (p>0.05). There were also no significant differences in hormone parameters (p>0.05). Moreover, no significant difference was observed between the groups regarding semen parameters and weekly coit frequency. However, a significant difference was found in clinical pregnancy rates between the IUI group (48.2%) and the TIC group (11%) (p<0.001).
Conclusion: Compared to TIC, IUI increases clinical pregnancy rates in infertile women with PCOS who underwent OI with CC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jogoh.2019.07.002 | DOI Listing |
F S Rep
December 2024
Ferring Pharmaceuticals Inc., Parsippany, New Jersey.
Objective: To evaluate the current utilization of advanced practice providers (APPs) within the field of reproductive endocrinology and infertility.
Design: Cross-sectional.
Setting: Web-based.
Obstet Gynecol Sci
January 2025
Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong.
This systematic review and meta-analysis aimed to summarize the pregnancy outcomes of women di-agnosed with genital tuberculosis (GTB) who spontaneously conceived or underwent intrauterine in-semination (IUI) or in vitro fertilization (IVF) after being treated with antitubercular therapy (ATT). Pub-lications from the PubMed, Medline, Embase, Ovid, Scopus, Web of Science, and Google Scholar data-bases were searched from December 20, 2021, to March 5, 2022. The outcomes are presented as pooled averages with 95% confidence intervals.
View Article and Find Full Text PDFEur J Med Res
December 2024
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Background: There are limited and controversial findings concerning ovulation induction using intrauterine and intramuscular human chorionic gonadotropin (hCG) injection compared to intramuscular hCG alone. The study aimed to examine the impact of intrauterine hCG injection, which is used to induce ovulation, on the efficacy of the intrauterine insemination (IUI) technique in patients with unexplained infertility.
Methods: A randomized controlled clinical trial was conducted involving 80 subjects with unexplained primary infertility at the infertility clinic of Al-Zahra Hospital in northwest Iran.
BMC Pregnancy Childbirth
December 2024
Department of Legal Medicine, Toho University School of Medicine, Tokyo, Japan.
Commun Med (Lond)
December 2024
Environmental Epigenetics Laboratory, Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, Finland.
Background: Assisted reproductive technology (ART) has been associated with increased risks for growth disturbance, disrupted imprinting as well as cardiovascular and metabolic disorders. However, the molecular mechanisms and whether they are a result of the ART procedures or the underlying subfertility are unknown.
Methods: We performed genome-wide DNA methylation (EPIC Illumina microarrays) and gene expression (mRNA sequencing) analyses for a total of 80 ART and 77 control placentas.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!